Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 15/20 | 0.48 |
| ▸ | CTSS | P25774 | 7/20 | 0.46 |
| ▸ | CTSL | P07711 | 6/20 | 0.46 |
| ▸ | CTSB | P07858 | 2/20 | 0.46 |
| ▸ | CAPN1 | P07384 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6808070 | 0.99 | CTSK (0.47) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL5497649 | 0.87 | CTSK (0.51) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL6808023 | 0.87 | CTSL (0.49) | CTSKCTSSCTSLCTSBCAPN1 | |
| Hydrochloric Acid SCHEMBL6809074 | 0.86 | CTSL (0.49) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL5495744 | 0.76 | CTSK (0.55) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL5490273 | 0.75 | CTSK (0.52) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL5496377 | 0.74 | CTSK (0.57) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL5493843 | 0.73 | CAPN1 (0.54) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL5492843 | 0.73 | CTSK (0.56) | CTSKCTSSCTSLCTSBCAPN1 | |
| SCHEMBL6808872 | 0.72 | TSHR (0.52) | CTSKCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040204368-A1 | Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient | ONO PHARMACEUTICAL CO., LTD. (JP) | 2004-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040204368-A1 | Oxadiazole derivative compounds and drugs containing these compounds as the active ingredient | ACIN1, CASP3, CASP7 | CTSK 451/4885CTSS 36/4885CTSL 263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.